Matralix: Difference between revisions
Appearance
Created page with "{{Infobox Startup |logo=Question 4 - matralix.jpg |status=Active |website=https://www.matralix.com/ |vertical=Biotechnology |trl=Unknown/Not Applicable |latest_funding=Undisclosed |founding_year=2014 |headquarters=Singapore }} {{PAGENAME}} is a COUNTRY-based startup developing TECHNOLOGY for APPLICATION. ==Technology== Describe the underlying science and technology of the startup here. Ideally, it should provide a layman introduction of any key differentiators and/or..." |
No edit summary |
||
| Line 9: | Line 9: | ||
|headquarters=Singapore | |headquarters=Singapore | ||
}} | }} | ||
{{PAGENAME}} is a | {{PAGENAME}} is a Singapore-based startup developing precision encapsulation systems. | ||
==Technology== | ==Technology== | ||
Matralix has developed a continuous flow-based, low footprint encapsulation system that requires minimal sample volumes and is highly tunable, allowing rapid screening and prototyping of formulations, while also being scalable<ref>{{Cite web |title=Matralix Pte Ltd |url=https://www.matralix.com/about-us |access-date=2025-12-27 |website=Matralix |language=en}}</ref>. They provide a self-contained, fully automated desktop factory to make lipid-based capsules and beads. | |||
== | ==Funding<ref>{{Cite web |title=Our Companies |url=https://seedscapital.sg/portfolio-companies/all-companies/ |access-date=2025-12-27 |website=seedscapital.sg |language=en}}</ref>== | ||
{{Startup/Funding history}} | |||
== | |||
= | |||
== References == | == References == | ||
{{Reflist}} | {{Reflist}} | ||
Latest revision as of 08:01, 27 December 2025
| Status | Active |
|---|---|
| Website | https://www.matralix.com/ |
| Vertical(s) | Biotechnology |
| Latest Funding Round | Undisclosed |
| Year founded | 2014 |
| Headquarters | Singapore |
| Technology Readiness Level | Unknown/Not Applicable |
Matralix is a Singapore-based startup developing precision encapsulation systems.
Technology
Matralix has developed a continuous flow-based, low footprint encapsulation system that requires minimal sample volumes and is highly tunable, allowing rapid screening and prototyping of formulations, while also being scalable[1]. They provide a self-contained, fully automated desktop factory to make lipid-based capsules and beads.
Funding[2]
| Funding History | |
|---|---|
| Investor | Round |
| Seeds Capital | Undisclosed |
Note: This list is community-maintained and may be incomplete or contain inaccuracies.
References
- ↑ "Matralix Pte Ltd". Matralix. Retrieved 2025-12-27.
- ↑ "Our Companies". seedscapital.sg. Retrieved 2025-12-27.
